Rare Disorders NZ has made a submission on Pharmac's proposal to fund Inotuzumab ozogamicin for the treatment of relapsed or refractory acute lymphoblastic leukaemia/lymphoma.
Read the full submission here.
Rare Disorders NZ is the collective voice of all people living with a rare disorder and their whānau. Our rare collective is made up of more than 150 disorder-specific support groups.
Our work is informed by the issues important to our collective. We work together to improve healthcare and wellbeing for everyone living with a rare health condition in New Zealand.
